In a previous trial on elderly patients with systolic hypertension, ARNi showed a trend of greater reduction in PWV, especially in the subgroup of patients who were in the upper quartile based on baseline PWV (Williams et al., 2017 ).
← all excerpts
Impact of angiotensin receptor-neprilysin inhibition on vascular function in heart failure with reduced ejection fraction: A pilot study.
1
—
—